 DIAPRESAN D
|
Montpellier
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.rec.x30 | $32.954,74 | (21/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $15.208,13 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $13.554,80 |
|
|
|
|
| 160/25 mg comp.rec.x30 | $40.135,38 | (21/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $17.622,72 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $15.880,06 |
|
|
|
|
| 320/12.5 mg comp.rec.x30 | $42.297,49 | (21/11/25) |
| PAMI |
|
| AF $16.651,21 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $25.063,23 AF $17.234,26 |
|
|
|
|
| 320/25 mg comp.rec.x30 | $42.555,77 | (21/11/25) |
|
|
|
| 80/12.5 mg comp.rec.x 30 | $27.897,11 | (21/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $11.815,87 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $10.138,11 |
|
|
|
|
| |
